BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 16832148)

  • 1. Differences in medical expenditure according to drug prices.
    Ueshima H
    Hypertens Res; 2006 May; 29(5):301-2. PubMed ID: 16832148
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of health costs associated with treatment of hypertension with a calcium channel blocker and angiotensin-converting enzyme inhibitor in the United States and Japan.
    Sakamaki Y; Sasamura H; Ikeda S; Ikegami N; Saruta T
    Hypertens Res; 2006 May; 29(5):333-8. PubMed ID: 16832153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [German Hypertension League update. What does the ALLHAT Study really mean?].
    MMW Fortschr Med; 2003 Jun; 145(23):45-6. PubMed ID: 12854226
    [No Abstract]   [Full Text] [Related]  

  • 4. [Added organ protection at little cost. Double savings with ACE inhibitors].
    MMW Fortschr Med; 2003 Nov; 145(48):63. PubMed ID: 14725008
    [No Abstract]   [Full Text] [Related]  

  • 5. [Health care too costly? Saving more than 10 million euros in 2 months!].
    Rappert B
    MMW Fortschr Med; 2003 Nov; 145(47):65. PubMed ID: 14725043
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of hypertension. Cost conscious prevention of complications].
    Kolloch RE
    MMW Fortschr Med; 2003 Nov; 145(47):64. PubMed ID: 14725042
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fully possible to reduce the costs of hypertension treatment].
    Wettermark B; Angman A; Hjemdahl P
    Lakartidningen; 2009 Jun 3-9; 106(23):1558-62. PubMed ID: 19583013
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessing the economic value of antihypertensive medications.
    Roth MS; Davenport RC; Simpson W
    Am J Manag Care; 1998 Sep; 4(9):1267-75. PubMed ID: 10185977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thiazides or ACE inhibitors? A drug-economic analysis].
    Aursnes I; Kristiansen IS
    Tidsskr Nor Laegeforen; 2004 Jun; 124(12):1668. PubMed ID: 15229722
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacotherapy of hypertension. How much can safely be saved?].
    Anlauf M
    MMW Fortschr Med; 2004 Apr; 146(15):57-8. PubMed ID: 15373022
    [No Abstract]   [Full Text] [Related]  

  • 11. An evaluation of cost variation in different brands of antihypertensive agents.
    Moharana AK; Khurana S; Lal A
    J Assoc Physicians India; 1998 Jun; 46(6):573-4. PubMed ID: 11273270
    [No Abstract]   [Full Text] [Related]  

  • 12. Consumption and costs of antihypertensive drugs in Mexico: are diuretic agents a standing technological trajectory?
    Altagracia-Martínez M; Kravzov-Jinich J; Guadarrama-Atrizco MD; Rubio-Poo C; Wertheimer AI
    Res Social Adm Pharm; 2006 Mar; 2(1):22-37. PubMed ID: 17138499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining the role of renin/angiotensin-targeted antihypertensive therapy in decreasing cardiovascular risk: evidence, guideline evolution, and questions to be resolved.
    Probstfield J
    J Fam Pract; 2009 Jun; 58(6 Suppl):S1-8. PubMed ID: 19508849
    [No Abstract]   [Full Text] [Related]  

  • 14. [The basic treatment of arterial hypertension (II). Pharmacological treatment].
    Pascual J; Orte L; Ortuño J
    Med Clin (Barc); 1994 Nov; 103(18):699-707. PubMed ID: 7808078
    [No Abstract]   [Full Text] [Related]  

  • 15. Antihypertensive pharmacotherapy in a developing economy: pattern, acquisition costs and conformity to international guidelines in a tertiary-care setting.
    Amira CO; Okubadejo NU
    J Hum Hypertens; 2006 Nov; 20(11):894-7. PubMed ID: 16915299
    [No Abstract]   [Full Text] [Related]  

  • 16. Left ventricular hypertrophy and clinical outcomes in hypertensive patients.
    Ruilope LM; Schmieder RE
    Am J Hypertens; 2008 May; 21(5):500-8. PubMed ID: 18437140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More bang for the buck in managing high blood pressure.
    Smith MD; McGhan W
    Bus Health; 1996 May; 14(5):44-7. PubMed ID: 10157918
    [No Abstract]   [Full Text] [Related]  

  • 18. [Medical economics of hypertension therapy].
    Yamazaki T
    Nihon Rinsho; 2008 Aug; 66(8):1601-4. PubMed ID: 18700564
    [No Abstract]   [Full Text] [Related]  

  • 19. Outcomes of sword swallowing and pharmaceutical step-therapy interventions.
    Curtiss FR
    J Manag Care Pharm; 2007 Apr; 13(3):284-6. PubMed ID: 17407396
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comrades! There must be some blood order in the field of hypertension!].
    Melander A
    Lakartidningen; 2005 Apr 4-10; 102(14):1068-70. PubMed ID: 15892478
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.